Compile Data Set for Download or QSAR
Report error Found 463 of affinity data for UniProtKB/TrEMBL: Q8NET8
LigandPNGBDBM50318486(CHEMBL422704 | 2-Methyl-2-(4-methyl-pent-3-enyl)-7...)
Affinity DataIC50: 2.01E+5nMAssay Description:Agonist activity at ionomycin-stimulated TRPV3 (unknown origin) channel desensitization in presence of carvacrolMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
LigandPNGBDBM50604152(CHEMBL5181908)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity against human TRPV3 expressed in HEK293 cells assessed as inhibition of 2-APb induced intracellular calcium accumulation incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/25/2023
Entry Details
PubMed
LigandPNGBDBM50645052(CHEMBL5564691)
Affinity DataIC50: 1.00E+5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
LigandPNGBDBM50321851(CHEMBL1173240 | US8796328, D | (R)-8-{5-[3-Methyl-...)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human TRPV3 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2012
Entry Details Article
PubMed
LigandPNGBDBM50318487(Cannabigerol | CHEMBL497318)
Affinity DataIC50: 6.60E+4nMAssay Description:Agonist activity at ionomycin-stimulated TRPV3 (unknown origin) channel desensitization in presence of carvacrolMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
LigandPNGBDBM50022307(CHEMBL3298242)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human TRPV3 expressed in CHOK1 cells assessed as inhibition of 2-APB-induced calcium flux incubated 10 mins prior to 2-APB add...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2015
Entry Details Article
PubMed
LigandPNGBDBM50022321(CHEMBL3298922)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human TRPV3 expressed in CHOK1 cells assessed as inhibition of 2-APB-induced calcium flux incubated 10 mins prior to 2-APB add...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2015
Entry Details Article
PubMed
LigandPNGBDBM50022322(CHEMBL3298923)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human TRPV3 expressed in CHOK1 cells assessed as inhibition of 2-APB-induced calcium flux incubated 10 mins prior to 2-APB add...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2015
Entry Details Article
PubMed
LigandPNGBDBM50022327(CHEMBL3299019)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human TRPV3 expressed in CHOK1 cells assessed as inhibition of 2-APB-induced calcium flux incubated 10 mins prior to 2-APB add...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2015
Entry Details Article
PubMed
LigandPNGBDBM50022347(CHEMBL3299022)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human TRPV3 expressed in CHOK1 cells assessed as inhibition of 2-APB-induced calcium flux incubated 10 mins prior to 2-APB add...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2015
Entry Details Article
PubMed
LigandPNGBDBM50022349(CHEMBL3299024)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human TRPV3 expressed in CHOK1 cells assessed as inhibition of 2-APB-induced calcium flux incubated 10 mins prior to 2-APB add...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2015
Entry Details Article
PubMed
LigandPNGBDBM50117636(CHEMBL3613642)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human TRPV3 receptor expressed in HEK293 cells assessed as inhibition of capsaicin-stimulated calcium flux after 10 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2016
Entry Details Article
PubMed
LigandPNGBDBM50532215(CBD-V | CBDV | Cannabidivarin | GWP42006)
Affinity DataIC50: 2.50E+4nMAssay Description:Agonist activity at ionomycin-stimulated TRPV3 (unknown origin) channel desensitization in presence of carvacrolMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
LigandPNGBDBM47255(US9012651, 160)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM47256(US9012651, 161)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM47258(US9012651, 169)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM47261(US9012651, 197)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155602(US9012651, 30)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155607(US9012651, 35)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155661(US9012651, 91)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155686(US9012651, 116)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155687(US9012651, 117)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155688(US9012651, 118)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155689(US9012651, 119)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155690(US9012651, 120)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155700(US9012651, 132)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155703(US9012651, 135)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155704(US9012651, 136)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155707(US9012651, 140)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155716(US9012651, 149)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155718(US9012651, 151)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155719(US9012651, 152)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155721(US9012651, 154)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155722(US9012651, 155)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155723(US9012651, 156)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155724(US9012651, 157)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155725(US9012651, 158)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155727(US9012651, 162)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155728(US9012651, 163)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155729(US9012651, 164)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155730(US9012651, 165)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155731(US9012651, 166)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155732(US9012651, 167)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155733(US9012651, 168)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155736(US9012651, 173)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155737(US9012651, 174)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155738(US9012651, 175)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155739(US9012651, 176)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155740(US9012651, 177)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

LigandPNGBDBM155741(US9012651, 178)
Affinity DataIC50: 2.00E+4nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2015
Entry Details
US Patent

Displayed 1 to 50 (of 463 total ) | Next | Last >>
Jump to: